View by Specialty

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

Alzheimer's Disease/Cognition News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 02, 2024
3 min read
Save

Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection

Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection

The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said.

SPONSORED CONTENT
October 02, 2024
2 min read
Save

Hypothyroidism does not worsen rate of cognitive decline for perimenopausal women

Hypothyroidism does not worsen rate of cognitive decline for perimenopausal women

Women with hypothyroidism receiving levothyroxine treatment experienced similar cognitive decline during menopause as those without thyroid disease, according to data published in Thyroid.

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

SPONSORED CONTENT
October 01, 2024
2 min read
Save

Tea, red wine among foods tied to lower risk for dementia

Tea, red wine among foods tied to lower risk for dementia

Adults who more frequently consumed several flavonoid-rich foods, like berries and tea, had a significantly lower risk for dementia, according to an analysis published in JAMA Network Open.

SPONSORED CONTENT
October 01, 2024
3 min read
Save

Gender, sexual identity may be associated with brain health outcomes

Gender, sexual identity may be associated with brain health outcomes

LGBTQ+ people may be more likely to experience adverse brain health outcomes, including late-life depression and dementia, compared with cisgender straight people, according to study results published in Neurology.

SPONSORED CONTENT
September 30, 2024
2 min read
Save

Diagnostic firm receives $7 million to advance novel Alzheimer’s biomarker platform

Diagnostic firm receives $7 million to advance novel Alzheimer’s biomarker platform

C2N Diagnostics has been awarded more than $7 million from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator initiative to advance a novel platform intended to boost Alzheimer’s disease biomarker detection.

SPONSORED CONTENT
September 27, 2024
2 min read
Save

Gut microbiota in older cancer survivors linked to cognitive function

Gut microbiota in older cancer survivors linked to cognitive function

ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.

SPONSORED CONTENT
September 26, 2024
2 min read
Save

MIND diet may reduce the risk for cognitive decline

MIND diet may reduce the risk for cognitive decline

Higher adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay, or MIND) diet reduced the risk for cognitive impairment, particularly in women, results from a cohort study published in Neurology showed.

SPONSORED CONTENT
September 26, 2024
4 min watch
Save

VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation

VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation

PHILADELPHIA — In this Healio Video Perspective from the Alzheimer’s Association International Conference, Johan Luthman, PhD, discusses new data from post hoc analyses evaluating the efficacy of Rexulti for Alzheimer’s-related agitation.

SPONSORED CONTENT
September 25, 2024
2 min read
Save

One in three former professional football players believe they have CTE

One in three former professional football players believe they have CTE

Around one-third of former professional football players perceived themselves as having chronic traumatic encephalopathy, according to results from a cross-sectional study published in JAMA Neurology.

SPONSORED CONTENT
September 24, 2024
2 min read
Save

Diabetes drug linked to reduced risk for dementia, Parkinson’s disease

Diabetes drug linked to reduced risk for dementia, Parkinson’s disease

The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails